This prospective observational study aims to investigate the association between physical activity and clinical pregnancy rates in women undergoing medically assisted reproduction. Additionally, it evaluates how cardiorespiratory fitness, cardiovascular health, psychosocial factors, sleep quality, stress, and cognitive function relate to reproductive outcomes.
Infertility affects approximately 8-12% of couples of reproductive age worldwide and represents a major medical and psychosocial burden. Medically assisted reproduction (MAR), including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), is widely used to address infertility, with more than 12,000 ART cycles performed annually in Switzerland. Despite advances in reproductive medicine, cumulative live birth rates following MAR remain moderate, highlighting the need to better understand modifiable factors that may influence treatment success. Emerging evidence suggests that general health-related factors-such as physical activity, cardiorespiratory fitness, cardiovascular health, stress, psychosocial well-being, sleep quality, and cognitive function-may play an important role in fertility and MAR outcomes. While moderate physical activity has been associated with improved clinical pregnancy and live birth rates in some studies, the current literature is inconsistent, with conflicting findings regarding the optimal level of activity. Similarly, obesity and cardiovascular risk factors are known to negatively affect fertility and ART outcomes, potentially through mechanisms such as systemic inflammation, insulin resistance, and impaired ovarian responsiveness. Retinal microvascular markers have emerged as early indicators of cardiovascular risk and may provide additional insights into pregnancy-related complications. Psychological stress, depression, poor sleep quality, and altered psychosocial health are prevalent among women experiencing infertility and may adversely affect reproductive physiology and treatment outcomes. Cognitive and psychosocial factors may further influence fertility indirectly through behavioral, hormonal, and lifestyle pathways. However, these domains are rarely assessed in an integrated and longitudinal manner in women undergoing MAR. The primary objective of this exploratory, prospective, longitudinal observational study is to examine the association between physical activity and clinical pregnancy rate following MAR in biological women experiencing infertility. Secondary objectives include assessing the relationship of cardiorespiratory fitness, body mass index, blood pressure, retinal microvascular health, psychosocial health, perceived stress, sleep quality, and cognitive function with clinical pregnancy outcomes. Additional objectives are to evaluate short-term changes in physical activity, stress, psychosocial health, sleep, and cognition during hormonal stimulation, as well as changes in retinal microvascular health after completion of the first trimester in cases of pregnancy.
Participants undergo a comprehensive, non-interventional longitudinal assessment of physical activity, cardiovascular health, psychosocial factors, sleep quality, and cognitive function integrated into routine medically assisted reproduction care.
University Hospital Basel
Basel, Switzerland
RECRUITINGClinical pregnancy rate (CPR) after medically assisted reproduction
Impact of Physical activity (PA) on clinical pregnancy rate (CPR) following medically assisted reproduction (MAR)
Time frame: During the 4 year observational period
Changes during hormonal stimulation: Physical activity behaviour
Physical activity and inactivity over the past seven days will be assessed using the International Physical Activity Questionnaire (IPAQ). Furthermore activity is measured by accelerometer before and during hormonal stimulation.
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Perceived stress
Psychological stress will be assessed using the Perceived Stress Scale. The PSS uses a 5-point Likert scale (0-4) for each item, with scores calculated as follows: Reverse Scoring: Positive items (e.g., PSS-10: items 4, 5, 7, 8) are reverse-scored (0 = 4, 1 = 3, 2 = 2, 3 = 1, 4 = 0). Total Score: Sum all item scores after reversing positive items. PSS-10: Range 0-40 Interpretation: Higher scores indicate greater perceived stress. General guidelines (not diagnostic) include: PSS-10: 0-13 (low), 14-26 (moderate), 27-40 (high)
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Depressive symptoms
Depressive symptoms will be assessed using the Patient Health Questionnaires-9 (PHQ-9). Scoring: Each question is scored 0 (not at all) to 3 (nearly every day), with a total score up to 27. Severity Levels: 0-4: Minimal depression 5-9: Mild 10-14: Moderate 15-19: Moderately severe 20-27: Severe.
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Anxiety symptoms
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Study Type
OBSERVATIONAL
Enrollment
115
Anxiety symptoms will be assessed using the Generalized Anxiety Disorder-7 questionnaire (GAD-7). Each answer is 0 (not at all), 1 (several days), 2 (more than half the days), or 3 (nearly every day). Total Score (0-21): Sum of all 7 items. Severity Levels: 0-4: Minimal anxiety. 5-9: Mild anxiety. 10-14: Moderate anxiety. 15-21: Severe anxiety.
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Body image
Body image will be assessed using the Body Appreciation Scale-2 (BAS-2). Body Appreciation Scale-2 (BAS-2) is a 10-item measure of one's acceptance, favorable opinions and respect of their own body. Response Options: Never - 1 Seldom - 2 Sometimes - 3 Often - 5 Always - 5 Scoring Procedures The mean of the 10 items is calculated for the total score. Higher scores indicate higher body appreciation.
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Sleep quality
Sleep disturbances will be assessed using the Insomnia Severity Index (ISI). The Insomnia Severity Index (ISI) uses a 0-28 scale, with each of its seven items rated 0 (none) to 4 (very severe), where higher scores mean worse insomnia, categorizing results into no insomnia (0-7), subthreshold (8-14), moderate (15-21), and severe (22-28) insomnia, indicating clinical significance and potential need for treatment as scores rise
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Quality of life
Quality of life will be assessed using the WHO-5 Well-Being Index. The WHO-5 Well-Being Index scaling uses a 6-point Likert scale (0 to 5) for five questions about the past two weeks, summing them for a raw score (0-25), then multiplying by 4 to get a final score (0-100), where 0 is worst and 100 is best; scores below 50 suggest poor well-being and potential depression needing further checks, with a score of 28 or below often indicating depression
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Cognitive function
Cognitive function will be tested by strooper task.
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Changes during hormonal stimulation: Nutrition
Dietary habits will be screened by mini-EAT (Eating Assessment Tool). Mini-Eating Assessment Tool (Mini-EAT) is a 9-item rapid dietary screener that includes fruits/vegetables, whole grains, refined grains, fish/seafood, legumes/nuts/seeds, low-fat dairy, high-fat dairy, and sweets consumption.
Time frame: preovulatory phase (day 5-14), during hormonal stimulation day (day 31-47), end of first trimester
Amount and type of gonadotropins used
Time frame: During the 4 year observational period
Ovulation trigger medication
Time frame: During the 4 year observational period
Amount of eggs collected per ovarian pick-up (OPU)
Time frame: During the 4 year observational period
Complications (Ovarian hyperstimulation syndrome, ovarian torsion, bleeding or infection after OPU)
Time frame: During the 4 year observational period
IVF fertilisation rate
Time frame: During the 4 year observational period
ICSI fertilisation rate
Time frame: During the 4 year observational period
Blastocyst development rate
Time frame: During the 4 year observational period
Blastocyst grading
Time frame: During the 4 year observational period
Evaluation of fresh vs. frozen embryo transfer
Time frame: During the 4 year observational period
Implantation rate
Time frame: During the 4 year observational period
Time to pregnancy
Time frame: During the 4 year observational period
Miscarriage rate (before twelve weeks of pregnancy)
Time frame: During the 4 year observational period
Pregnancy complications
Time frame: During the 4 year observational period
Preterm birth
Time frame: During the 4 year observational period
Cumulative life birth rate
Time frame: During the 4 year observational period
Fetal malformations
Time frame: During the 4 year observational period
Perinatal death
Time frame: During the 4 year observational period